Comparative in vitro activity of cefepime against strains isolated from intensive care and haematology patients

Acta Clinica Belgica

Volumn 55, Issue 1, 2000, Pages 16-21

  Vanpoucke, Hilde ^a   Claeys, G ^a   De Grauwe, E ^a   Verschraegen, G ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Cefepime; Haematology; Intensive care

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; DRUG DERIVATIVE; ENZYME INHIBITOR; IMIPENEM; PENICILLANIC ACID; PENICILLIN DERIVATIVE; PIPERACILLIN; TAZOBACTAM; THIENAMYCIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIURIA; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; ENTEROBACTER INFECTION; GRAM NEGATIVE INFECTION; HUMAN; INTENSIVE CARE; MICROBIOLOGY; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION;

ANTI-INFECTIVE AGENTS; BACTEREMIA; BACTERIAL INFECTIONS; BACTERIURIA; BETA-LACTAMASES; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; CIPROFLOXACIN; ENTEROBACTERIACEAE INFECTIONS; ENZYME INHIBITORS; HUMANS; IMIPENEM; INTENSIVE CARE; PENICILLANIC ACID; PENICILLINS; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; THIENAMYCINS;

EID: 0033649468     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1080/17843286.2000.11754267     Document Type: Article

References (7)

1. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev. 1995; 8: 557-84.
2. Jacoby GA, Carreras I. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother. 1990; 34: 858-62.
3. Livermore, D.M. β-Lactamases of Pseudomonas aeruginosa. Antibiot. Chemother. (Basel). 1991; 44: 215-20
4. Joan C. Fung-Tomc, Ph. D. Fourth-Generation Cephalosporins. Clinical Microbiology Newsletter. 1997; 19, No 17: 129-36
5. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard M7-A3, Vol. 13 No 25. NCCLS, Villanova, PA, 1993
6. Philippon A, Arlet G, Lagrange PH. Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis. 1994; 13, Suppl 1: 517-29.
7. Frei R, Jones RN, Pignatari AC, Yamane N, Marco F, Hoban DJ. Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime. Diagn Microbiol Infect Dis. 1994; 18: 167-73.